Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2024

TCT 112: The Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy

Presenter: Kazuki Muramatsu

October 29, 2024

Presentation TCT 2024

Interatrial Shunts (IASD): From Theory to Clinical Trials

Presenter: Javed Butler

October 28, 2024

News Daily News

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

L.A. McKeown

October 15, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

Presentation NY Valves 2024

Safety, Efficacy, and Long Term Outcomes With Using Pre-Procedural Predictive Modeling for Left Atrial Appendage Closure Preplanning

Presenter: Kirollos Gabrah

June 05, 2024

Presentation NY Valves 2024

Treatment of Residual Shunt After PFO Closure Using Mullins Sheath-Facilitated Delivery of the Gore Cardioform Septal Occluder Device

Presenter: Francesca Isabella Galasso

June 05, 2024

Presentation NY Valves 2024

Comparison of the Short-Term WATCHMAN FLX Healing by TEE and CCTA: A Prospective Comparative Cohort Study

Presenter: Lauren Sharan Ranard

June 05, 2024

Presentation NY Valves 2024

Left Atrial Appendage Peri-Device Leak Closure Is Safe and Feasible: A Case Series

Presenter: Karim Al-Azizi

June 05, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation Miami Valves 2024

Navigating an unusual shunt post TAVR

Presenter: Victor Becerra-Gonzales

February 01, 2024

Advertisement

TCT 112: The Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy

Interatrial Shunts (IASD): From Theory to Clinical Trials

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Safety, Efficacy, and Long Term Outcomes With Using Pre-Procedural Predictive Modeling for Left Atrial Appendage Closure Preplanning

Treatment of Residual Shunt After PFO Closure Using Mullins Sheath-Facilitated Delivery of the Gore Cardioform Septal Occluder Device

Comparison of the Short-Term WATCHMAN FLX Healing by TEE and CCTA: A Prospective Comparative Cohort Study

Left Atrial Appendage Peri-Device Leak Closure Is Safe and Feasible: A Case Series

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Navigating an unusual shunt post TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content